Home - X4 Pharmaceuticals

x4-homepage-hero-bg-lg

Rare

Resolve.

Driving progress for people living with rare immune disorders

ABBEY

Living with Chronic Neutropenia

recent news

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2025
X4 Pharmaceuticals Announces Upcoming Presentation of Phase 2 Chronic Neutropenia Trial Data at the 30th Annual EHA Congress
May 14, 2025
X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
May 1, 2025

© Copyright 2025 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics